EMEA (Europe, Middle East and Africa) Ophthalmic Drugs Market Report 2017

October 2017 | 110 pages | ID: E0230C1B80DEN
QYResearch

Abstracts

In this report, the EMEA Ophthalmic Drugs market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report split EMEA into Europe, the Middle East and Africa, With sales (K Pcs), revenue (Million USD), market share and growth rate of Ophthalmic Drugs for these regions, from 2012 to 2022 (forecast)

• Europe: Germany, France, UK, Russia, Italy and Benelux;
• Middle East: Saudi Arabia, Israel, UAE and Iran;
• Africa: South Africa, Nigeria, Egypt and Algeria.

EMEA Ophthalmic Drugs market competition by top manufacturers/players, with Ophthalmic Drugs sales volume (K Pcs), price (USD/Pcs), revenue (Million USD) and market share for each manufacturer/player; the top players including

• Pfizer
• Merck
• Glaxosmithkline
• Abbott Laboratories
• Johnson and Johnson
• Bayer
• Shire
• Roche Holding
• Novartis
• Akorn
• Eyemed
• Senju Pharmaceutical
• Sun Pharmaceuticals Industries
• Allergan
• Valeant
• Regeneron
• Eyegate Pharmaceuticals
• Lpath Incorporated
• Santen Pharmaceutical
• Cipla Pharmaceuticals

On the basis of product, this report displays the sales volume (K Pcs), revenue (Million USD), product price (USD/Pcs), market share and growth rate of each type, primarily split into

• Solutions
• Ointments
• Other

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume (K Pcs), market share and growth rate of Ophthalmic Drugs for each application, including

• Hospital Pharmacies
• Online Pharmacies
• Independent Pharmacies & Drug Stores

If you have any special requirements, please let us know and we will offer you the report as you want.

Contents

EMEA (Europe, Middle East and Africa) Ophthalmic Drugs Market Report 2017

1 OPHTHALMIC DRUGS OVERVIEW

1.1 Product Overview and Scope of Ophthalmic Drugs
1.2 Classification of Ophthalmic Drugs
  1.2.1 EMEA Ophthalmic Drugs Market Size (Sales) Comparison by Type (2012-2022)
  1.2.2 EMEA Ophthalmic Drugs Market Size (Sales) Market Share by Type (Product Category) in 2016
  1.2.3 Solutions
  1.2.4 Ointments
  1.2.5 Other
1.3 EMEA Ophthalmic Drugs Market by Application/End Users
  1.3.1 EMEA Ophthalmic Drugs Sales (Volume) and Market Share Comparison by Application (2012-2022
  1.3.2 Hospital Pharmacies
  1.3.3 Online Pharmacies
  1.3.4 Independent Pharmacies & Drug Stores
1.4 EMEA Ophthalmic Drugs Market by Region
  1.4.1 EMEA Ophthalmic Drugs Market Size (Value) Comparison by Region (2012-2022)
  1.4.2 Europe Status and Prospect (2012-2022)
  1.4.3 Middle East Status and Prospect (2012-2022)
  1.4.4 Africa Status and Prospect (2012-2022)
1.5 EMEA Market Size (Value and Volume) of Ophthalmic Drugs (2012-2022)
  1.5.1 EMEA Ophthalmic Drugs Sales and Growth Rate (2012-2022)
  1.5.2 EMEA Ophthalmic Drugs Revenue and Growth Rate (2012-2022)

2 EMEA OPHTHALMIC DRUGS COMPETITION BY MANUFACTURERS/PLAYERS/SUPPLIERS, REGION, TYPE AND APPLICATION

2.1 EMEA Ophthalmic Drugs Market Competition by Players/Manufacturers
  2.1.1 EMEA Ophthalmic Drugs Sales Volume and Market Share of Major Players (2012-2017)
  2.1.2 EMEA Ophthalmic Drugs Revenue and Share by Players (2012-2017)
  2.1.3 EMEA Ophthalmic Drugs Sale Price by Players (2012-2017)
2.2 EMEA Ophthalmic Drugs (Volume and Value) by Type/Product Category
  2.2.1 EMEA Ophthalmic Drugs Sales and Market Share by Type (2012-2017)
  2.2.2 EMEA Ophthalmic Drugs Revenue and Market Share by Type (2012-2017)
  2.2.3 EMEA Ophthalmic Drugs Sale Price by Type (2012-2017)
2.3 EMEA Ophthalmic Drugs (Volume) by Application
2.4 EMEA Ophthalmic Drugs (Volume and Value) by Region
  2.4.1 EMEA Ophthalmic Drugs Sales and Market Share by Region (2012-2017)
  2.4.2 EMEA Ophthalmic Drugs Revenue and Market Share by Region (2012-2017)
  2.4.3 EMEA Ophthalmic Drugs Sales Price by Region (2012-2017)

3 EUROPE OPHTHALMIC DRUGS (VOLUME, VALUE AND SALES PRICE), BY PLAYERS, COUNTRIES, TYPE AND APPLICATION

3.1 Europe Ophthalmic Drugs Sales and Value (2012-2017)
  3.1.1 Europe Ophthalmic Drugs Sales Volume and Growth Rate (2012-2017)
  3.1.2 Europe Ophthalmic Drugs Revenue and Growth Rate (2012-2017)
3.2 Europe Ophthalmic Drugs Sales and Market Share by Type
3.3 Europe Ophthalmic Drugs Sales and Market Share by Application
3.4 Europe Ophthalmic Drugs Sales Volume and Value (Revenue) by Countries
  3.4.1 Europe Ophthalmic Drugs Sales Volume by Countries (2012-2017)
  3.4.2 Europe Ophthalmic Drugs Revenue by Countries (2012-2017)
  3.4.3 Germany Ophthalmic Drugs Sales and Growth Rate (2012-2017)
  3.4.4 France Ophthalmic Drugs Sales and Growth Rate (2012-2017)
  3.4.5 UK Ophthalmic Drugs Sales and Growth Rate (2012-2017)
  3.4.6 Russia Ophthalmic Drugs Sales and Growth Rate (2012-2017)
  3.4.7 Italy Ophthalmic Drugs Sales and Growth Rate (2012-2017)
  3.4.8 Benelux Ophthalmic Drugs Sales and Growth Rate (2012-2017)

4 MIDDLE EAST OPHTHALMIC DRUGS (VOLUME, VALUE AND SALES PRICE), BY REGION, TYPE AND APPLICATION

4.1 Middle East Ophthalmic Drugs Sales and Value (2012-2017)
  4.1.1 Middle East Ophthalmic Drugs Sales Volume and Growth Rate (2012-2017)
  4.1.2 Middle East Ophthalmic Drugs Revenue and Growth Rate (2012-2017)
4.2 Middle East Ophthalmic Drugs Sales and Market Share by Type
4.3 Middle East Ophthalmic Drugs Sales and Market Share by Application
4.4 Middle East Ophthalmic Drugs Sales Volume and Value (Revenue) by Countries
  4.4.1 Middle East Ophthalmic Drugs Sales Volume by Countries (2012-2017)
  4.4.2 Middle East Ophthalmic Drugs Revenue by Countries (2012-2017)
  4.4.3 Saudi Arabia Ophthalmic Drugs Sales and Growth Rate (2012-2017)
  4.4.4 Israel Ophthalmic Drugs Sales and Growth Rate (2012-2017)
  4.4.5 UAE Ophthalmic Drugs Sales and Growth Rate (2012-2017)
  4.4.6 Iran Ophthalmic Drugs Sales and Growth Rate (2012-2017)

5 AFRICA OPHTHALMIC DRUGS (VOLUME, VALUE AND SALES PRICE) BY PLAYERS, COUNTRIES, TYPE AND APPLICATION

5.1 Africa Ophthalmic Drugs Sales and Value (2012-2017)
  5.1.1 Africa Ophthalmic Drugs Sales Volume and Growth Rate (2012-2017)
  5.1.2 Africa Ophthalmic Drugs Revenue and Growth Rate (2012-2017)
5.2 Africa Ophthalmic Drugs Sales and Market Share by Type
5.3 Africa Ophthalmic Drugs Sales and Market Share by Application
5.4 Africa Ophthalmic Drugs Sales Volume and Value (Revenue) by Countries
  5.4.1 Africa Ophthalmic Drugs Sales Volume by Countries (2012-2017)
  5.4.2 Africa Ophthalmic Drugs Revenue by Countries (2012-2017)
  5.4.3 South Africa Ophthalmic Drugs Sales and Growth Rate (2012-2017)
  5.4.4 Nigeria Ophthalmic Drugs Sales and Growth Rate (2012-2017)
  5.4.5 Egypt Ophthalmic Drugs Sales and Growth Rate (2012-2017)
  5.4.6 Algeria Ophthalmic Drugs Sales and Growth Rate (2012-2017)

6 EMEA OPHTHALMIC DRUGS MANUFACTURERS/PLAYERS PROFILES AND SALES DATA

6.1 Pfizer
  6.1.1 Company Basic Information, Manufacturing Base and Competitors
  6.1.2 Ophthalmic Drugs Product Type, Application and Specification
    6.1.2.1 Product A
    6.1.2.2 Product B
  6.1.3 Pfizer Ophthalmic Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  6.1.4 Main Business/Business Overview
6.2 Merck
  6.2.1 Company Basic Information, Manufacturing Base and Competitors
  6.2.2 Ophthalmic Drugs Product Type, Application and Specification
    6.2.2.1 Product A
    6.2.2.2 Product B
  6.2.3 Merck Ophthalmic Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  6.2.4 Main Business/Business Overview
6.3 Glaxosmithkline
  6.3.1 Company Basic Information, Manufacturing Base and Competitors
  6.3.2 Ophthalmic Drugs Product Type, Application and Specification
    6.3.2.1 Product A
    6.3.2.2 Product B
  6.3.3 Glaxosmithkline Ophthalmic Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  6.3.4 Main Business/Business Overview
6.4 Abbott Laboratories
  6.4.1 Company Basic Information, Manufacturing Base and Competitors
  6.4.2 Ophthalmic Drugs Product Type, Application and Specification
    6.4.2.1 Product A
    6.4.2.2 Product B
  6.4.3 Abbott Laboratories Ophthalmic Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  6.4.4 Main Business/Business Overview
6.5 Johnson and Johnson
  6.5.1 Company Basic Information, Manufacturing Base and Competitors
  6.5.2 Ophthalmic Drugs Product Type, Application and Specification
    6.5.2.1 Product A
    6.5.2.2 Product B
  6.5.3 Johnson and Johnson Ophthalmic Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  6.5.4 Main Business/Business Overview
6.6 Bayer
  6.6.1 Company Basic Information, Manufacturing Base and Competitors
  6.6.2 Ophthalmic Drugs Product Type, Application and Specification
    6.6.2.1 Product A
    6.6.2.2 Product B
  6.6.3 Bayer Ophthalmic Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  6.6.4 Main Business/Business Overview
6.7 Shire
  6.7.1 Company Basic Information, Manufacturing Base and Competitors
  6.7.2 Ophthalmic Drugs Product Type, Application and Specification
    6.7.2.1 Product A
    6.7.2.2 Product B
  6.7.3 Shire Ophthalmic Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  6.7.4 Main Business/Business Overview
6.8 Roche Holding
  6.8.1 Company Basic Information, Manufacturing Base and Competitors
  6.8.2 Ophthalmic Drugs Product Type, Application and Specification
    6.8.2.1 Product A
    6.8.2.2 Product B
  6.8.3 Roche Holding Ophthalmic Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  6.8.4 Main Business/Business Overview
6.9 Novartis
  6.9.1 Company Basic Information, Manufacturing Base and Competitors
  6.9.2 Ophthalmic Drugs Product Type, Application and Specification
    6.9.2.1 Product A
    6.9.2.2 Product B
  6.9.3 Novartis Ophthalmic Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  6.9.4 Main Business/Business Overview
6.10 Akorn
  6.10.1 Company Basic Information, Manufacturing Base and Competitors
  6.10.2 Ophthalmic Drugs Product Type, Application and Specification
    6.10.2.1 Product A
    6.10.2.2 Product B
  6.10.3 Akorn Ophthalmic Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  6.10.4 Main Business/Business Overview
6.11 Eyemed
6.12 Senju Pharmaceutical
6.13 Sun Pharmaceuticals Industries
6.14 Allergan
6.15 Valeant
6.16 Regeneron
6.17 Eyegate Pharmaceuticals
6.18 Lpath Incorporated
6.19 Santen Pharmaceutical
6.20 Cipla Pharmaceuticals

7 OPHTHALMIC DRUGS MANUFACTURING COST ANALYSIS

7.1 Ophthalmic Drugs Key Raw Materials Analysis
  7.1.1 Key Raw Materials
  7.1.2 Price Trend of Key Raw Materials
  7.1.3 Key Suppliers of Raw Materials
  7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
  7.2.1 Raw Materials
  7.2.2 Labor Cost
  7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Ophthalmic Drugs

8 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

8.1 Ophthalmic Drugs Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Ophthalmic Drugs Major Manufacturers in 2016
8.4 Downstream Buyers

9 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

9.1 Marketing Channel
  9.1.1 Direct Marketing
  9.1.2 Indirect Marketing
  9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
  9.2.1 Pricing Strategy
  9.2.2 Brand Strategy
  9.2.3 Target Client
9.3 Distributors/Traders List

10 MARKET EFFECT FACTORS ANALYSIS

10.1 Technology Progress/Risk
  10.1.1 Substitutes Threat
  10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change

11 EMEA OPHTHALMIC DRUGS MARKET FORECAST (2017-2022)

11.1 EMEA Ophthalmic Drugs Sales, Revenue and Price Forecast (2017-2022)
  11.1.1 EMEA Ophthalmic Drugs Sales and Growth Rate Forecast (2017-2022)
  11.1.2 EMEA Ophthalmic Drugs Revenue and Growth Rate Forecast (2017-2022)
  11.1.3 EMEA Ophthalmic Drugs Price and Trend Forecast (2017-2022)
11.2 EMEA Ophthalmic Drugs Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
11.3 Europe Ophthalmic Drugs Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
11.4 Middle Eastt Ophthalmic Drugs Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
11.5 Africa Ophthalmic Drugs Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
11.6 EMEA Ophthalmic Drugs Sales Forecast by Type (2017-2022)
11.7 EMEA Ophthalmic Drugs Sales Forecast by Application (2017-2022)

12 RESEARCH FINDINGS AND CONCLUSION

13 APPENDIX

13.1 Methodology/Research Approach
  13.1.1 Research Programs/Design
  13.1.2 Market Size Estimation
  13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
  13.2.1 Secondary Sources
  13.2.2 Primary Sources
13.3 Disclaimer


The report requires updating with new data and is sent in 2-3 business days after order is placed.

List Of Tables

LIST OF TABLES AND FIGURES

Figure Product Picture of Ophthalmic Drugs
Figure EMEA Ophthalmic Drugs Sales Volume (K Pcs) by Type (2012-2022)
Figure EMEA Ophthalmic Drugs Sales Volume Market Share by Type (Product Category) in 2016
Figure Solutions Product Picture
Figure Ointments Product Picture
Figure Other Product Picture
Figure EMEA Ophthalmic Drugs Sales Volume (K Pcs) by Application (2012-2022)
Figure EMEA Sales Market Share of Ophthalmic Drugs by Application in 2016
Figure Hospital Pharmacies Examples
Table Key Downstream Customer in Hospital Pharmacies
Figure Online Pharmacies Examples
Table Key Downstream Customer in Online Pharmacies
Figure Independent Pharmacies & Drug Stores Examples
Table Key Downstream Customer in Independent Pharmacies & Drug Stores
Figure EMEA Ophthalmic Drugs Market Size (Million USD) by Region (2012-2022)
Figure Europe Ophthalmic Drugs Revenue (Million USD) and Growth Rate (2012-2022)
Figure Europe Ophthalmic Drugs Revenue (Million USD) Status and Forecast by Countries
Figure Middle East Ophthalmic Drugs Revenue (Million USD) and Growth Rate (2012-2022)
Figure Middle East Ophthalmic Drugs Revenue (Million USD) Status and Forecast by Countries
Figure Africa Ophthalmic Drugs Revenue (Million USD) and Growth Rate (2012-2022)
Figure Africa Ophthalmic Drugs Revenue (Million USD) Status and Forecast by Countries
Figure EMEA Ophthalmic Drugs Sales Volume and Growth Rate (2012-2022)
Figure EMEA Ophthalmic Drugs Revenue (Million USD) and Growth Rate (2012-2022)
Figure EMEA Ophthalmic Drugs Market Major Players Product Sales Volume (K Pcs) (2012-2017)
Table EMEA Ophthalmic Drugs Sales Volume (K Pcs) of Major Players (2012-2017)
Table EMEA Ophthalmic Drugs Sales Share by Players (2012-2017)
Figure 2016 Ophthalmic Drugs Sales Share by Players
Figure 2017 Ophthalmic Drugs Sales Share by Players
Figure EMEA Ophthalmic Drugs Market Major Players Product Revenue (Million USD) (2012-2017)
Table EMEA Ophthalmic Drugs Revenue (Million USD) by Players (2012-2017)
Table EMEA Ophthalmic Drugs Revenue Share by Players (2012-2017)
Table 2016 EMEA Ophthalmic Drugs Revenue Share by Players
Table 2017 EMEA Ophthalmic Drugs Revenue Share by Players
Table EMEA Ophthalmic Drugs Sale Price (USD/Pcs) by Players (2012-2017)
Table EMEA Ophthalmic Drugs Sales (K Pcs) and Market Share by Type (2012-2017)
Table EMEA Ophthalmic Drugs Sales Share by Type (2012-2017)
Figure Sales Market Share of Ophthalmic Drugs by Type (2012-2017)
Figure EMEA Ophthalmic Drugs Sales Market Share by Type (2012-2017)
Table EMEA Ophthalmic Drugs Revenue (Million USD) and Market Share by Type (2012-2017)
Table EMEA Ophthalmic Drugs Revenue Share by Type (2012-2017)
Figure Revenue Market Share of Ophthalmic Drugs by Type in 2016
Table EMEA Ophthalmic Drugs Sale Price (USD/Pcs) by Type (2012-2017)
Table EMEA Ophthalmic Drugs Sales (K Pcs) and Market Share by Application (2012-2017)
Table EMEA Ophthalmic Drugs Sales Share by Application (2012-2017)
Figure Sales Market Share of Ophthalmic Drugs by Application (2012-2017)
Figure EMEA Ophthalmic Drugs Sales Market Share by Application in 2016
Table EMEA Ophthalmic Drugs Sales (K Pcs) and Market Share by Region (2012-2017)
Table EMEA Ophthalmic Drugs Sales Share by Region (2012-2017)
Figure Sales Market Share of Ophthalmic Drugs by Region (2012-2017)
Figure EMEA Ophthalmic Drugs Sales Market Share in 2016
Table EMEA Ophthalmic Drugs Revenue (Million USD) and Market Share by Region (2012-2017)
Table EMEA Ophthalmic Drugs Revenue Share by Region (2012-2017)
Figure Revenue Market Share of Ophthalmic Drugs by Region (2012-2017)
Figure EMEA Ophthalmic Drugs Revenue Market Share Regions in 2016
Table EMEA Ophthalmic Drugs Sales Price (USD/Pcs) by Region (2012-2017)
Figure Europe Ophthalmic Drugs Sales (K Pcs) and Growth Rate (2012-2017)
Figure Europe Ophthalmic Drugs Revenue and Growth Rate (2012-2017)
Table Europe Ophthalmic Drugs Sales (K Pcs) by Type (2012-2017)
Table Europe Ophthalmic Drugs Market Share by Type (2012-2017)
Figure Europe Ophthalmic Drugs Market Share by Type in 2016
Table Europe Ophthalmic Drugs Sales (K Pcs) by Application (2012-2017)
Table Europe Ophthalmic Drugs Market Share by Application (2012-2017)
Figure Europe Ophthalmic Drugs Market Share by Application in 2016
Table Europe Ophthalmic Drugs Sales (K Pcs) by Countries (2012-2017)
Table Europe Ophthalmic Drugs Sales Market Share by Countries (2012-2017)
Figure Europe Ophthalmic Drugs Sales Market Share by Countries (2012-2017)
Figure Europe Ophthalmic Drugs Sales Market Share by Countries in 2016
Table Europe Ophthalmic Drugs Revenue (Million USD) by Countries (2012-2017)
Table Europe Ophthalmic Drugs Revenue Market Share by Countries (2012-2017)
Figure Europe Ophthalmic Drugs Revenue Market Share by Countries (2012-2017)
Figure Europe Ophthalmic Drugs Revenue Market Share by Countries in 2016
Figure Germany Ophthalmic Drugs Sales (K Pcs) and Growth Rate (2012-2017)
Figure France Ophthalmic Drugs Sales (K Pcs) and Growth Rate (2012-2017)
Figure UK Ophthalmic Drugs Sales (K Pcs) and Growth Rate (2012-2017)
Figure Russia Ophthalmic Drugs Sales (K Pcs) and Growth Rate (2012-2017)
Figure Italy Ophthalmic Drugs Sales (K Pcs) and Growth Rate (2012-2017)
Figure Benelux Ophthalmic Drugs Sales (K Pcs) and Growth Rate (2012-2017)
Figure Middle East Ophthalmic Drugs Sales (K Pcs) and Growth Rate (2012-2017)
Figure Middle East Ophthalmic Drugs Revenue (Million USD) and Growth Rate (2012-2017)
Table Middle East Ophthalmic Drugs Sales (K Pcs) by Type (2012-2017)
Table Middle East Ophthalmic Drugs Market Share by Type (2012-2017)
Figure Middle East Ophthalmic Drugs Market Share by Type (2012-2017)
Table Middle East Ophthalmic Drugs Sales (K Pcs) by Applications (2012-2017)
Table Middle East Ophthalmic Drugs Market Share by Applications (2012-2017)
Figure Middle East Ophthalmic Drugs Sales Market Share by Application in 2016
Table Middle East Ophthalmic Drugs Sales Volume (K Pcs) by Countries (2012-2017)
Table Middle East Ophthalmic Drugs Sales Volume Market Share by Countries (2012-2017)
Figure Middle East Ophthalmic Drugs Sales Volume Market Share by Countries in 2016
Table Middle East Ophthalmic Drugs Revenue (Million USD) by Countries (2012-2017)
Table Middle East Ophthalmic Drugs Revenue Market Share by Countries (2012-2017)
Figure Middle East Ophthalmic Drugs Revenue Market Share by Countries (2012-2017)
Figure Middle East Ophthalmic Drugs Revenue Market Share by Countries in 2016
Figure Saudi Arabia Ophthalmic Drugs Sales (K Pcs) and Growth Rate (2012-2017)
Figure Israel Ophthalmic Drugs Sales (K Pcs) and Growth Rate (2012-2017)
Figure UAE Ophthalmic Drugs Sales (K Pcs) and Growth Rate (2012-2017)
Figure Iran Ophthalmic Drugs Sales (K Pcs) and Growth Rate (2012-2017)
Figure Africa Ophthalmic Drugs Sales (K Pcs) and Growth Rate (2012-2017)
Figure Africa Ophthalmic Drugs Revenue (Million USD) and Growth Rate (2012-2017)
Table Africa Ophthalmic Drugs Sales (K Pcs) by Type (2012-2017)
Table Africa Ophthalmic Drugs Sales Market Share by Type (2012-2017)
Figure Africa Ophthalmic Drugs Sales Market Share by Type (2012-2017)
Figure Africa Ophthalmic Drugs Sales Market Share by Type in 2016
Table Africa Ophthalmic Drugs Sales (K Pcs) by Application (2012-2017)
Table Africa Ophthalmic Drugs Sales Market Share by Application (2012-2017)
Figure Africa Ophthalmic Drugs Sales Market Share by Application (2012-2017)
Table Africa Ophthalmic Drugs Sales Volume (K Pcs) by Countries (2012-2017)
Table Africa Ophthalmic Drugs Sales Market Share by Countries (2012-2017)
Figure Africa Ophthalmic Drugs Sales Market Share by Countries (2012-2017)
Figure Africa Ophthalmic Drugs Sales Market Share by Countries in 2016
Table Africa Ophthalmic Drugs Revenue (Million USD) by Countries (2012-2017)
Table Africa Ophthalmic Drugs Revenue Market Share by Countries (2012-2017)
Figure Africa Ophthalmic Drugs Revenue Market Share by Countries (2012-2017)
Figure Africa Ophthalmic Drugs Revenue Market Share by Countries in 2016
Figure South Africa Ophthalmic Drugs Sales (K Pcs) and Growth Rate (2012-2017)
Figure Nigeria Ophthalmic Drugs Sales (K Pcs) and Growth Rate (2012-2017)
Figure Egypt Ophthalmic Drugs Sales (K Pcs) and Growth Rate (2012-2017)
Figure Algeria Ophthalmic Drugs Sales (K Pcs) and Growth Rate (2012-2017)
Table Pfizer Ophthalmic Drugs Basic Information List
Table Pfizer Ophthalmic Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Pfizer Ophthalmic Drugs Sales (K Pcs) and Growth Rate (2012-2017)
Figure Pfizer Ophthalmic Drugs Sales Market Share in EMEA (2012-2017)
Figure Pfizer Ophthalmic Drugs Revenue Market Share in EMEA (2012-2017)
Table Merck Ophthalmic Drugs Basic Information List
Table Merck Ophthalmic Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Merck Ophthalmic Drugs Sales (K Pcs) and Growth Rate (2012-2017)
Figure Merck Ophthalmic Drugs Sales Market Share in EMEA (2012-2017)
Figure Merck Ophthalmic Drugs Revenue Market Share in EMEA (2012-2017)
Table Glaxosmithkline Ophthalmic Drugs Basic Information List
Table Glaxosmithkline Ophthalmic Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Glaxosmithkline Ophthalmic Drugs Sales (K Pcs) and Growth Rate (2012-2017)
Figure Glaxosmithkline Ophthalmic Drugs Sales Market Share in EMEA (2012-2017)
Figure Glaxosmithkline Ophthalmic Drugs Revenue Market Share in EMEA (2012-2017)
Table Abbott Laboratories Ophthalmic Drugs Basic Information List
Table Abbott Laboratories Ophthalmic Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Abbott Laboratories Ophthalmic Drugs Sales (K Pcs) and Growth Rate (2012-2017)
Figure Abbott Laboratories Ophthalmic Drugs Sales Market Share in EMEA (2012-2017)
Figure Abbott Laboratories Ophthalmic Drugs Revenue Market Share in EMEA (2012-2017)
Table Johnson and Johnson Ophthalmic Drugs Basic Information List
Table Johnson and Johnson Ophthalmic Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Johnson and Johnson Ophthalmic Drugs Sales (K Pcs) and Growth Rate (2012-2017)
Figure Johnson and Johnson Ophthalmic Drugs Sales Market Share in EMEA (2012-2017)
Figure Johnson and Johnson Ophthalmic Drugs Revenue Market Share in EMEA (2012-2017)
Table Bayer Ophthalmic Drugs Basic Information List
Table Bayer Ophthalmic Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Bayer Ophthalmic Drugs Sales (K Pcs) and Growth Rate (2012-2017)
Figure Bayer Ophthalmic Drugs Sales Market Share in EMEA (2012-2017)
Figure Bayer Ophthalmic Drugs Revenue Market Share in EMEA (2012-2017)
Table Shire Ophthalmic Drugs Basic Information List
Table Shire Ophthalmic Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Shire Ophthalmic Drugs Sales (K Pcs) and Growth Rate (2012-2017)
Figure Shire Ophthalmic Drugs Sales Market Share in EMEA (2012-2017)
Figure Shire Ophthalmic Drugs Revenue Market Share in EMEA (2012-2017)
Table Roche Holding Ophthalmic Drugs Basic Information List
Table Roche Holding Ophthalmic Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Roche Holding Ophthalmic Drugs Sales (K Pcs) and Growth Rate (2012-2017)
Figure Roche Holding Ophthalmic Drugs Sales Market Share in EMEA (2012-2017)
Figure Roche Holding Ophthalmic Drugs Revenue Market Share in EMEA (2012-2017)
Table Novartis Ophthalmic Drugs Basic Information List
Table Novartis Ophthalmic Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Novartis Ophthalmic Drugs Sales (K Pcs) and Growth Rate (2012-2017)
Figure Novartis Ophthalmic Drugs Sales Market Share in EMEA (2012-2017)
Figure Novartis Ophthalmic Drugs Revenue Market Share in EMEA (2012-2017)
Table Akorn Ophthalmic Drugs Basic Information List
Table Akorn Ophthalmic Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Akorn Ophthalmic Drugs Sales (K Pcs) and Growth Rate (2012-2017)
Figure Akorn Ophthalmic Drugs Sales Market Share in EMEA (2012-2017)
Figure Akorn Ophthalmic Drugs Revenue Market Share in EMEA (2012-2017)
Table Eyemed Ophthalmic Drugs Basic Information List
Table Senju Pharmaceutical Ophthalmic Drugs Basic Information List
Table Sun Pharmaceuticals Industries Ophthalmic Drugs Basic Information List
Table Allergan Ophthalmic Drugs Basic Information List
Table Valeant Ophthalmic Drugs Basic Information List
Table Regeneron Ophthalmic Drugs Basic Information List
Table Eyegate Pharmaceuticals Ophthalmic Drugs Basic Information List
Table Lpath Incorporated Ophthalmic Drugs Basic Information List
Table Santen Pharmaceutical Ophthalmic Drugs Basic Information List
Table Cipla Pharmaceuticals Ophthalmic Drugs Basic Information List
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Ophthalmic Drugs
Figure Manufacturing Process Analysis of Ophthalmic Drugs
Figure Ophthalmic Drugs Industrial Chain Analysis
Table Raw Materials Sources of Ophthalmic Drugs Major Manufacturers in 2016
Table Major Buyers of Ophthalmic Drugs
Table Distributors/Traders List
Figure EMEA Ophthalmic Drugs Sales (K Pcs) and Growth Rate Forecast (2017-2022)
Figure EMEA Ophthalmic Drugs Revenue and Growth Rate Forecast (2017-2022)
Figure EMEA Ophthalmic Drugs Price (USD/Pcs) and Trend Forecast (2017-2022)
Table EMEA Ophthalmic Drugs Sales (K Pcs) Forecast by Region (2017-2022)
Figure EMEA Ophthalmic Drugs Sales Market Share Forecast by Region (2017-2022)
Table EMEA Ophthalmic Drugs Revenue (Million USD) Forecast by Region (2017-2022)
Figure EMEA Ophthalmic Drugs Revenue Market Share Forecast by Region (2017-2022)
Table Europe Ophthalmic Drugs Sales (K Pcs) Forecast by Countries (2017-2022)
Figure Europe Ophthalmic Drugs Sales Market Share Forecast by Countries (2017-2022)
Table Europe Ophthalmic Drugs Revenue (Million USD) Forecast by Countries (2017-2022)
Figure Europe Ophthalmic Drugs Revenue Market Share Forecast by Countries (2017-2022)
Table Middle East Ophthalmic Drugs Sales (K Pcs) Forecast by Countries (2017-2022)
Figure Middle East Ophthalmic Drugs Sales Market Share Forecast by Countries (2017-2022)
Table Middle East Ophthalmic Drugs Revenue (Million USD) Forecast by Countries (2017-2022)
Figure Middle East Ophthalmic Drugs Revenue Market Share Forecast by Countries (2017-2022)
Table Africa Ophthalmic Drugs Sales (K Pcs) Forecast by Countries (2017-2022)
Figure Africa Ophthalmic Drugs Sales Market Share Forecast by Countries (2017-2022)
Table Africa Ophthalmic Drugs Revenue (Million USD) Forecast by Countries (2017-2022)
Figure Africa Ophthalmic Drugs Revenue Market Share Forecast by Countries (2017-2022)
Table EMEA Ophthalmic Drugs Sales (K Pcs) Forecast by Type (2017-2022)
Figure EMEA Ophthalmic Drugs Sales Market Share Forecast by Type (2017-2022)
Table EMEA Ophthalmic Drugs Sales (K Pcs) Forecast by Application (2017-2022)
Figure EMEA Ophthalmic Drugs Sales Market Share Forecast by Application (2017-2022)
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources